Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.4K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
The Ras Gene02:38

The Ras Gene

6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic signatures mark early peripheral human B lineage bifurcation and differential transcriptional profiles in mature populations.

Nature communications·2026
Same author

Rewiring ALS by modulating the autophagy receptor SQSTM1.

Stem cell reports·2026
Same author

Lewy bodies are surrounded by granulovacuolar degeneration bodies in dementia with Lewy bodies.

Brain pathology (Zurich, Switzerland)·2026
Same author

Guiding Principles: Current Practices and Considerations for Benchmarking Human Gastrointestinal Organoids.

Cellular and molecular gastroenterology and hepatology·2026
Same author

Atlas of human gut-associated lymphoid tissue reveals immunomodulatory interactions of B cells.

Science immunology·2026
Same author

Plasma signals of lung tumor promotion for molecular cancer prevention.

Cell·2026

Related Experiment Video

Updated: Jun 4, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.8K

Oncogenic PIK3CA corrupts growth factor signaling specificity.

Ralitsa R Madsen1,2, Alix Le Marois3, Oliwia N Mruk4

  • 1Cell Signaling Laboratory, Department of Oncology, University College London Cancer Institute Paul O'Gorman Building, University College London, London, WC1E 6BT, UK. rmadsen001@dundee.ac.uk.

Molecular Systems Biology
|December 20, 2024
PubMed
Summary

The PIK3CA^H1047R^ oncogene corrupts growth factor signaling, altering phosphoinositide 3-kinase (PI3K)/AKT pathway information transfer and amplifying specific receptor signals. This finding offers new therapeutic strategies for cancer.

Keywords:
Growth Factor SpecificityInformation TransferPI3K Signaling DynamicsSingle-cell Biology

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.3K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.5K

Related Experiment Videos

Last Updated: Jun 4, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.8K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.3K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.5K

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Cancer research

Background:

  • Understanding growth factor signal encoding in the phosphoinositide 3-kinase (PI3K)/AKT pathway is limited by technical challenges.
  • The impact of oncogenic mutations on PI3K/AKT pathway signaling fidelity remains unclear.

Purpose of the Study:

  • To develop a kinetic, single-cell framework for quantifying PI3K-specific information transfer.
  • To investigate how the PIK3CA^H1047R^ oncogene alters growth factor signaling and pathway fidelity.

Main Methods:

  • Live-cell imaging of PI3K/AKT activity reporters.
  • Multiplexed CyTOF measurements of PI3K/AKT and RAS/ERK signaling markers.
  • Single-cell kinetic framework for information transfer calculations.

Main Results:

  • The PIK3CA^H1047R^ oncogene does not act as a simple constitutive activator.
  • Dose-dependent PIK3CA^H1047R^ expression corrupted growth factor-induced information transfer fidelity.
  • Preferential amplification of epidermal growth factor receptor (EGFR) signaling over IGF1 and insulin receptor signaling was observed.
  • PIK3CA^H1047R^ increased both the mean and heterogeneity of signaling responses.

Conclusions:

  • Oncogenic PIK3CA^H1047R^ corrupts information transfer in a growth factor-dependent manner.
  • This provides new opportunities for therapeutic intervention by tuning receptor-specific PI3K pathway outputs.